John Barr Biography and Net Worth

Director of Apollo Endosurgery


Since March 2019, Mr. Barr has served as a member of our Board. Since January 2018, Mr. Barr has served as an Operating Partner for Altamont Capital Partners, a private equity firm. From October 2014 through August 2017, Mr. Barr served as the chief executive officer of Surgical Specialties, Inc., a manufacturer of surgical instruments. From May 2012 through August 2013, Mr. Barr served as the President, Global Surgical at Bausch & Lomb Holdings Incorporated, an eye health products company. Mr. Barr previously served on the Board of Directors of Valeritas Holdings Inc., a medical technology company focused on the treatment of diabetes. Mr. Barr holds a B.S. in Bioengineering from the University of Pennsylvania and an M.B.A. from Northwestern University. We believe Mr. Barr’s qualifications to serve on our Board include his extensive leadership experience in the medical device and surgical products industries.

What is John R. Barr's net worth?

The estimated net worth of John R. Barr is at least $0.00 as of March 10th, 2021. Barr owns 16,070 shares of Apollo Endosurgery stock worth more than $0 as of April 19th. This net worth approximation does not reflect any other assets that Barr may own. Learn More about John R. Barr's net worth.

How do I contact John R. Barr?

The corporate mailing address for Barr and other Apollo Endosurgery executives is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. Apollo Endosurgery can also be reached via phone at (512) 279-5100 and via email at [email protected]. Learn More on John R. Barr's contact information.

Has John R. Barr been buying or selling shares of Apollo Endosurgery?

John R. Barr has not been actively trading shares of Apollo Endosurgery during the last quarter. Most recently, on Wednesday, March 10th, John R. Barr bought 10,000 shares of Apollo Endosurgery stock. The stock was acquired at an average cost of $5.89 per share, with a total value of $58,900.00. Following the completion of the transaction, the director now directly owns 16,070 shares of the company's stock, valued at $94,652.30. Learn More on John R. Barr's trading history.

Who are Apollo Endosurgery's active insiders?

Apollo Endosurgery's insider roster includes John Barr (Director), Jeffrey Black (CFO), Neil Gagnon (Major Shareholder), Chas Mckhann (CEO), and David Pacitti (Director). Learn More on Apollo Endosurgery's active insiders.

John R. Barr Insider Trading History at Apollo Endosurgery

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2021Buy10,000$5.89$58,900.0016,070View SEC Filing Icon  
See Full Table

John R. Barr Buying and Selling Activity at Apollo Endosurgery

This chart shows John R Barr's buying and selling at Apollo Endosurgery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apollo Endosurgery Company Overview

Apollo Endosurgery logo
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $9.94
Low: $9.87
High: $10.00

2 Week Range

Now: N/A

Volume

1,658,800 shs

Average Volume

1,432,125 shs

Market Capitalization

$579.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.31